首页> 外文OA文献 >Topical Application of Retinyl Palmitate-Loaded Nanotechnology-Based Drug Delivery Systems for the Treatment of Skin Aging
【2h】

Topical Application of Retinyl Palmitate-Loaded Nanotechnology-Based Drug Delivery Systems for the Treatment of Skin Aging

机译:棕榈酸视黄基酯纳米技术为基础的药物递送系统在皮肤老化中的局部应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this study was to perform a structural characterization and evaluate the in vitro safety profile and in vitro antioxidant activity of liquid crystalline systems (LCS) with and without retinyl palmitate (RP). LCS containing polyether functional siloxane (PFS) as a surfactant, silicon glycol copolymer (SGC) as oil phase, and water in the ratios 30 : 25 : 45 and 40 : 50 : 10 with (OLS nu = RP-loaded opaque liquid system and TLS nu = RP-loaded transparent liquid system, respectively) and without (OLS and TLS, respectively) RP were studied. Samples were characterized using polarized light microscopy (PLM) and rheology analysis. in vitro safety profile was evaluated using red cell hemolysis and in vitro cytotoxicity assays. in vitro antioxidant activity was performed by the DPPH method. PLM analysis showed the presence of lamellar LCS just to TLS. Regardless of the presence of RP, the rheological studies showed the pseudoplastic behavior of the formulations. the results showed that the incorporation of RP in LCS improved the safety profile of the drug. in vitro antioxidant activity suggests that LCS presented a higher capacity to maintain the antioxidant activity of RP. PFS-based systems may be a promising platform for RP topical application for the treatment of skin aging.
机译:这项研究的目的是进行结构表征,并评估带有和不带有棕榈酸视黄酯(RP)的液晶系统(LCS)的体外安全性和体外抗氧化活性。 LCS包含聚醚官能硅氧烷(PFS)作为表面活性剂,聚乙二醇共聚物(SGC)作为油相,水比为30:25:45和40:50:10(OLS nu = RP负载的不透明液体系统,研究了TLS nu =加载RP的透明液体系统和没有RP(分别为OLS和TLS)的RP。使用偏光显微镜(PLM)和流变学分析对样品进行表征。使用红细胞溶血和体外细胞毒性试验评估了体外安全性。通过DPPH方法进行体外抗氧化活性。 PLM分析表明仅存在于TLS的层状LCS。无论是否存在RP,流变学研究均显示出制剂的假塑性行为。结果表明,在LCS中掺入RP可以改善药物的安全性。体外抗氧化活性表明LCS具有较高的维持RP抗氧化活性的能力。基于PFS的系统可能是RP局部治疗皮肤老化的有前途的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号